A101G (p.Ala101Gly) variant of AKT3 (Q9Y243)

A101G (p.Ala101Gly) in AKT3 (Q9Y243) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.77 / 1. The record also includes population frequency data.

A101G (p.Ala101Gly) variant details